British Journal of Dermatology

Papers
(The H4-Index of British Journal of Dermatology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
银屑病皮肤细胞中的小分子 RNA 促进炎症发生239
Correction206
P91: Cutaneous adverse events of immune check point inhibitors nivolumab, pembrolizumab and atezolizumab: a multicentric study138
Adding up the desmosomal genes causing syndromes with hair and skin involvement: identification of TUFT1 by state-of-the-art whole-genome sequencing97
Atypical melanocytes of an atypical Spitz tumour observed with optical super-high magnification dermoscopy96
How to score the impact of treatment on cutaneous neurofibromas in clinical trials90
The association of anxiety with granuloma annulare: a case–control study of the National Institutes of Health ‘All of Us’ research programme83
Delusional infestation – do not be scared!80
O11 The human discs large protein (Dlg1) controls connexin 43 (Cx43) plasma membrane localization and gap junctional communication in keratinocytes75
O06 Exploring host–microbiome–immune interactions using singular and multispecies inoculations in optimized 3D skin models74
Interactive effect of genetic and environmental risk factors on psoriasis: current evidence and future directives70
Editor's Choice – John Ingram – Sep 202369
BH13: Scarring alopecia affecting a congenital melanocytic naevus in a patient with frontal fibrosing alopecia68
P100: Efficacy of current treatments under study in patients with alopecia areata68
P15: Twenty years of the UK Dermatology Clinical Trials Network: past, present and future67
CPC11: Bromoderma in a patient with chronic obstructive pulmonary disease66
开展健康宣传活动，禁售日光浴床，以减少皮肤癌: 合理利用医疗预算61
H10: A Sweet diagnosis to make: the history of Robert Douglas Sweet and acute febrile neutrophilic dermatosis58
BH09: Frontal fibrosing alopecia in men: is it any different?57
Issue Information56
P52: Opportunities for implementing a patient‐initiated follow‐up pathway in patients with psoriasis completing narrowband ultraviolet B phototherapy56
DP27: Maculopapular cutaneous mastocytosis mimicking seborrhoeic folliculitis54
P53: Office 365: Microsoft Lists as a tool for a secure online second‐line/systemic drug database53
DP12: An 11‐year mystery52
Higher proportion of cellulitis in severe lymphoedema51
Integrating artificial intelligence into skin cancer pathways: the opportunities and obstacles51
520 - Evaluating the expression of OX40 and OX40 ligand in lesional skin versus non-lesional skin in volunteers with atopic dermatitis and in healthy control skin50
Greater understanding about differences in the long-term course of eczema and their risk factors in children50
561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial49
A current need for the use of improved and standardized outcome measures by clinical studies of pemphigus49
A guide to using the core outcome set for eczema48
GD07: The use of the Dermatology Life Quality Index suite of patient‐reported outcome measures in neglected tropical diseases of the skin: a systematic review47
Editor's Choice – John Ingram – December 202345
Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review44
Risankizumab versus apremilast in the era of skin clearance44
O22 Unravelling the pathophysiology of KLICK syndrome to identify therapeutically targetable pathways44
Proliferative actinic keratoses are associated with adverse clinical outcomes relative to actinic keratoses without a proliferative growth pattern44
Mosaic EGFR exon 20 in-frame insertion pathogenic variants are associated with papular epidermal naevus with ‘skyline’ basal cell layer (PENS)44
Correction to: Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded c43
Newborn genome screening (the Generation Study): the advent of presymptomatic diagnosis for genodermatoses43
CD03 Contact sensitization to shellac: a possible marker of fragrance allergy42
010 Enhanced outcome prediction in cutaneous squamous cell carcinoma using deep-learning and computational histopathology (cSCCnet)42
0.18322706222534